Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening.
Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily; patients taking it as 5/50/1000 mg extended-release tablets should take 2 tablets together once daily.
The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg.
Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is necessary for patients with mild renal impairment.
If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, the starting dose of metformin hydrochloride is 500mg or 750mg once daily, and the maximum daily dose is 1000mg.
If the estimated glomerular filtration rate is less than 45mL/min/1.73m2, discontinue treatment immediately.
Improvement of glycemic control in type 2 diabetes mellitus
View approved original textHide original text
This medication is used in conjunction with diet and exercise therapy to help manage blood sugar levels in patients with type 2 diabetes. It particularly aids in more effective blood sugar control when used in combination with dapagliflozin, sitagliptin, and metformin, thereby contributing to the health improvement of those who struggle with blood sugar management.
How to take
Adult dose
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine once daily with a meal, preferably in the evening.
Patients taking this medicine as 10/100/1000 mg extended-release tablets should take 1 tablet once daily; patients taking it as 5/50/1000 mg extended-release tablets should take 2 tablets together once daily.
The dose of extended-release metformin hydrochloride is determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding 2000 mg.
Patients with renal impairment require dose adjustment according to renal function; no dose adjustment is necessary for patients with mild renal impairment.
If the estimated glomerular filtration rate (eGFR) is 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, the starting dose of metformin hydrochloride is 500mg or 750mg once daily, and the maximum daily dose is 1000mg.
If the estimated glomerular filtration rate is less than 45mL/min/1.73m2, discontinue treatment immediately.
Precautions
This medication contains a mixture of ingredients used in the treatment of diabetes.
First, the sitagliptin component may rarely cause serious allergic reactions. Such reactions can occur within three months of starting the medication, so if symptoms like skin rash or difficulty breathing develop, it is essential to stop taking the medication immediately and consult a doctor.
Moreover, sitagliptin poses a risk of acute inflammation of the pancreas (acute pancreatitis), so if abdominal pain, nausea, or vomiting occur during treatment, medical personnel must be informed immediately.
The metformin ingredient may rarely lead to a severe metabolic disorder known as lactic acidosis. This condition can cause symptoms such as vomiting, abdominal pain, muscle pain, difficulty breathing, and lethargy, and immediate medical attention should be sought if it occurs.
This medication is not to be administered to patients with moderate to severe renal impairment, dehydration, severe infection, heart failure, acute myocardial infarction, or other kidney or heart-related issues.
Moreover, this medication must be discontinued before examinations involving radiological iodinated contrast agents, and it can only be resumed after confirming normal kidney function post-examination.
Patients who are pregnant or who have severely impaired liver function should also not use this medication.
During treatment with this medication, side effects such as hypoglycemia, fluid loss, urinary and genital infections may occur; if symptoms arise, immediate consultation with a physician is necessary.
In particular, patients with reduced fluid volume or low blood pressure, elderly individuals, and those with decreased kidney function should take extra caution and undergo regular kidney function tests.
This medication can induce a severe metabolic complication known as diabetic ketoacidosis, so if symptoms of ketoacidosis appear even when blood sugar levels are not elevated, immediate treatment should be sought.
Finally, alcohol consumption should be avoided while taking this medication, and if symptoms of dehydration or severe gastrointestinal disturbances occur, the medication should be discontinued and a doctor consulted.
Side effects
Hypersensitivity
anaphylaxis
angioedema
Stevens-Johnson syndrome
exfoliative skin disorders
acute pancreatitis
lactic acidosis
hypoglycemia
genital infections
vulvitis
Show 99 moreCollapse
balanitis
fungal infections
perineal necrosis
reduced fluid volume
thirst
diabetic ketoacidosis
dizziness
constipation
dry mouth
back pain
dysuria
polyuria
nocturia
interstitial nephritis
elevated hematocrit
increased blood creatinine
dyslipidemia
urinary tract infection
decreased renal creatinine clearance
acute kidney failure
rash
urticaria
cutaneous vasculitis
myalgia
limb pain
back pain
interstitial lung disease
pruritus
thrombocytopenia
rhabdomyolysis
gastroesophageal reflux disease
upper abdominal pain
diverticulum
intestinal perforation
chronic pancreatitis
hyperglycemia
paresthesia
cerebral infarction
nerve compression
sinusitis
diverticulitis
pelvic inflammatory disease
pneumonia
pulmonary tuberculosis
weakness
pain
ligament sprain
keratitis
chronic obstructive pulmonary disease
hemoptysis
cerebral hemorrhage
peripheral artery occlusion
angina
myocardial infarction
bile duct stones
cholangitis
alcoholic cirrhosis
depression
suicide attempt
gastric adenocarcinoma
acute pyelonephritis
chest pain
dyspepsia
nausea
diarrhea
vomiting
urinary retention
increased alanine aminotransferase
increased aspartate aminotransferase
decreased appetite
headache
nasopharyngitis
chest discomfort
peripheral edema
generalized edema
hunger
vaginal discharge
menstrual irregularities
itching
arthralgia
musculoskeletal pain
limb pain
muscle weakness
myalgia
osteoarthritis
ligament sprain
diabetic retinopathy
cough
dyspnea
orthostatic hypotension
palpitations
insomnia
fatty liver
gallbladder polyps
tinnitus
taste impairment
erythema
urticaria
rash
Not everyone experiences these, and they can vary from person to person.
Storage
Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius.
Appearance and packaging
Appearance
Pale yellow, bilaterally convex, oval sustained-release film-coated tablet
Package unit
30 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.